BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16860020)

  • 1. Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting.
    Hong YJ; Jeong MH; Lim SY; Lee SR; Hong SN; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2006 Aug; 98(3):341-5. PubMed ID: 16860020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft plaque detected on intravascular ultrasound is the strongest predictor of in-stent restenosis: an intravascular ultrasound study.
    Sahara M; Kirigaya H; Oikawa Y; Yajima J; Nagashima K; Hara H; Ogasawara K; Aizawa T
    Eur Heart J; 2004 Nov; 25(22):2026-33. PubMed ID: 15541839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.
    Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1477-83. PubMed ID: 16308495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study.
    Niccoli G; Dato I; Imaeva AE; Antonazzo Panico R; Roberto M; Burzotta F; Aurigemma C; Trani C; Gramegna M; Leone AM; Porto I; Crea F
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):917-25. PubMed ID: 24618655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preinterventional peak monocyte count and in-stent intimal hyperplasia after coronary stent implantation in human coronary arteries.
    Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
    Clin Cardiol; 2005 Nov; 28(11):512-8. PubMed ID: 16450794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.
    Kim JY; Ko YG; Shim CY; Park S; Hwang KC; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Am J Cardiol; 2005 Nov; 96(10):1384-8. PubMed ID: 16275183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of plasma C-reactive protein in predicting in-stent restenosis in patients with stable angina after coronary stenting.
    Xu YL; Li JJ; Xu B; Zhu CG; Yang YJ; Chen JL; Qiao SB; Yuan JQ; Qin XW; Ma WH; Yao M; Liu HB; Wu YJ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2011 Mar; 124(6):845-50. PubMed ID: 21518590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
    Zhao C; Yang L; Mao L; Zhong L; Li X; Wei S
    Coron Artery Dis; 2013 Aug; 24(5):357-60. PubMed ID: 23835667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-stent restenosis-prone coronary plaque composition: A retrospective virtual histology-intravascular ultrasound study.
    Seo DJ; Kim YK; Seo YH; Song IG; Kim KH; Kwon TG; Park HW; Bae JH
    Cardiol J; 2018; 25(1):7-13. PubMed ID: 29064537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
    Tanındı A; Ekici B; Töre HF
    Turk Kardiyol Dern Ars; 2015 Jul; 43(5):457-64. PubMed ID: 26148078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial remodeling patterns before intervention predict diffuse in-stent restenosis: an intravascular ultrasound study.
    Sahara M; Kirigaya H; Oikawa Y; Yajima J; Ogasawara K; Satoh H; Nagashima K; Hara H; Nakatsu Y; Aizawa T
    J Am Coll Cardiol; 2003 Nov; 42(10):1731-8. PubMed ID: 14642680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
    Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M
    Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One month follow-up C-reactive protein may be a useful predictor of angiographic restenosis and long-term clinical outcomes after bare metal stent implantation.
    Hahn JY; Kim HS; Koo BK; Na SH; Chung JW; Youn TJ; Chung WY; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB
    Int J Cardiol; 2006 May; 109(2):267-9. PubMed ID: 16644391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
    Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
    Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation.
    Niccoli G; Conte M; Cosentino N; Todaro D; Brugaletta S; Montone RA; Minelli S; Fracassi F; Galiffa V; Leone AM; Burzotta F; Porto I; Trani C; Crea F
    J Invasive Cardiol; 2011 Jan; 23(1):16-20. PubMed ID: 21183765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
    Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
    Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.